Journal article
The human FcγRII (CD32) family of leukocyte FCR in health and disease
JC Anania, AM Chenoweth, BD Wines, P MarkHogarth
Frontiers in Immunology | FRONTIERS MEDIA SA | Published : 2019
Open access
Abstract
FcγRs have been the focus of extensive research due to their key role linking innate and humoral immunity and their implication in both inflammatory and infectious disease. Within the human FcγR family FcγRII (activatory FcγRIIa and FcγRIIc, and inhibitory FcγRIIb) are unique in their ability to signal independent of the common γ chain. Through improved understanding of the structure of these receptors and how this affects their function we may be able to better understand how to target FcγR specific immune activation or inhibition, which will facilitate in the development of therapeutic monoclonal antibodies in patients where FcγRII activity may be desirable for efficacy. This review is foc..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This work was funded by Australian National Health and Medical Research Council: PMH, JA, AC, and BW supported by NHMRC project grants 1079946, 1067484, and grants-in-aid from the Pendergast Trust and Walkom Trust.